Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/643"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label | |
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_numb_subjects | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose |
"0.333"
|
| ?:Evidence_type | |
| ?:Evidence_value | |
| ?:content |
"Route of administration: oral
study duration: 0.5mg oral triazolam was administered alone or after 3 days of pretreatment with .333 mg tid erythromycin
population: 16 males (including 5 smokers)
ages: 19-42
AUC_i/AUC: 41.4/20.1 = 2.06"
|
| dc:creator | |
| dc:date |
"10/29/2007 13:08:09"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ erythromycin_increases_auc_triazolam, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1902 }